Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 707

1.

Comment on "Degradation of the Polymeric Brominated Flame Retardant "Polymeric FR" by Heat and UV Exposure".

Buffey K, Davis JW, Kram S, Lukas C, O'Connor JC, Hunter SE.

Environ Sci Technol. 2019 Sep 17;53(18):11056-11057. doi: 10.1021/acs.est.9b02088. Epub 2019 Sep 5. No abstract available.

PMID:
31486638
2.

A GENETIC VARIANT IN THE BCL2 GENE ASSOCIATES WITH ADALIMUMAB RESPONSE IN HIDRADENITIS SUPPURATIVA CLINICAL TRIALS AND REGULATES EXPRESSION OF BCL2.

Liu M, Degner J, Georgantas RW, Nader A, Mostafa NM, Teixeira HD, Williams DA, Kirsner RS, Nichols AJ, Davis JW, Waring JF.

J Invest Dermatol. 2019 Aug 26. pii: S0022-202X(19)33147-1. doi: 10.1016/j.jid.2019.06.152. [Epub ahead of print]

PMID:
31465739
3.

Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance.

Herlemann A, Huang HC, Alam R, Tosoian JJ, Kim HL, Klein EA, Simko JP, Chan JM, Lane BR, Davis JW, Davicioni E, Feng FY, McCue P, Kim H, Den RB, Bismar TA, Carroll PR, Cooperberg MR.

Prostate Cancer Prostatic Dis. 2019 Aug 27. doi: 10.1038/s41391-019-0167-9. [Epub ahead of print]

PMID:
31455846
4.

Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African Americans.

Xu J, Chang WS, Tsai CW, Bau DT, Davis JW, Thompson TC, Logothetis CJ, Gu J.

Carcinogenesis. 2019 Aug 13. pii: bgz139. doi: 10.1093/carcin/bgz139. [Epub ahead of print]

PMID:
31408512
5.

A predictive grading scale for acute cholecystitis.

Siada S, Jeffcoach D, Dirks RC, Wolfe MM, Kwok AM, Sue LP, Davis JW.

Trauma Surg Acute Care Open. 2019 Jul 11;4(1):e000324. doi: 10.1136/tsaco-2019-000324. eCollection 2019.

6.

The impact of obesity on severity of solid organ injury in the adult population at a Level I trauma center.

Chen AK, Jeffcoach D, Stivers JC, McCullough KA, Dirks RC, Boehnke RJ, Sue L, Kwok AM, Wolfe MM, Davis JW.

Trauma Surg Acute Care Open. 2019 Jul 12;4(1):e000318. doi: 10.1136/tsaco-2019-000318. eCollection 2019.

7.

Correction to: Unintended consequences of decreased PSA-based prostate cancer screening.

Ahlering T, Huynh LM, Kaler KS, Williams S, Osann K, Joseph J, Lee D, Davis JW, Abaza R, Kaouk J, Patel V, Kim IY, Porter J, Hu JC.

World J Urol. 2019 Jul 22. doi: 10.1007/s00345-019-02877-6. [Epub ahead of print]

PMID:
31332511
8.

Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort.

Nudelman KNH, Lin J, Lane KA, Nho K, Kim S, Faber KM, Risacher SL, Foroud TM, Gao S, Davis JW, Weiner MW, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2019;71(1):33-43. doi: 10.3233/JAD-190010.

PMID:
31322561
9.

An urban stormwater runoff mortality syndrome in juvenile coho salmon.

Chow MI, Lundin JI, Mitchell CJ, Davis JW, Young G, Scholz NL, McIntyre JK.

Aquat Toxicol. 2019 Sep;214:105231. doi: 10.1016/j.aquatox.2019.105231. Epub 2019 Jun 20.

10.

Toward the Development and Application of an Environmental Risk Assessment Framework for Microplastic.

Gouin T, Becker RA, Collot AG, Davis JW, Howard B, Inawaka K, Lampi M, Ramon BS, Shi J, Hopp PW.

Environ Toxicol Chem. 2019 Jun 24. doi: 10.1002/etc.4529. [Epub ahead of print] Review.

PMID:
31233238
11.

Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging.

Truong M, Baack Kukreja JE, Rais-Bahrami S, Barashi NS, Wang B, Nuffer Z, Park JH, Lam K, Frye TP, Nix JW, Thomas JV, Feng C, Chapin BF, Davis JW, Hollenberg G, Oto A, Eggener SE, Joseph JV, Weinberg E, Messing EM.

Eur Urol Oncol. 2019 May;2(3):257-264. doi: 10.1016/j.euo.2018.08.008. Epub 2019 Jan 4.

PMID:
31200839
12.

Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone.

Efstathiou E, Davis JW, Pisters L, Li W, Wen S, McMullin RP, Gormley M, Ricci D, Titus M, Hoang A, Zurita AJ, Tran N, Peng W, Kheoh T, Molina A, Troncoso P, Logothetis CJ.

Eur Urol. 2019 Oct;76(4):418-424. doi: 10.1016/j.eururo.2019.05.010. Epub 2019 Jun 6.

PMID:
31176622
13.

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement.

Cooperberg MR, Carroll PR, Dall'Era MA, Davies BJ, Davis JW, Eggener SE, Feng FY, Lin DW, Morgan TM, Morgans AK, Spratt DE, Taneja SS, Penson DF.

Eur Urol. 2019 Sep;76(3):268-272. doi: 10.1016/j.eururo.2019.05.013. Epub 2019 May 23.

PMID:
31128968
14.

Who Hurts More? A Multicenter Prospective Study of In-Hospital Opioid Use in Pediatric Trauma Patients in the Midwest.

Pelaez CA, Davis JW, Spilman SK, Guzzo HM, Wetjen KM, Randell KA, Ortega HW, Pitcher GJ, Kenardy J, Ramirez MR.

J Am Coll Surg. 2019 May 21. pii: S1072-7515(19)30344-8. doi: 10.1016/j.jamcollsurg.2019.05.021. [Epub ahead of print]

PMID:
31125609
15.

Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of "regression to the mean" using routine clinical features with correlating biochemical relapse rates.

Altok M, Troncoso P, Achim MF, Matin SF, Gonzalez GN, Davis JW.

Asian J Androl. 2019 May 17. doi: 10.4103/aja.aja_29_19. [Epub ahead of print]

16.

Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial Design.

Reichard CA, Kukreja J, Gregg JR, Bathala TK, Achim MF, Wang X, Davis JW, Nguyen QN, Chapin BF.

Eur Urol Focus. 2019 May 7. pii: S2405-4569(19)30132-4. doi: 10.1016/j.euf.2019.04.016. [Epub ahead of print]

PMID:
31076357
17.

Biochemical recurrence after radical prostatectomy: Current status of its use as a treatment endpoint and early management strategies.

McCormick BZ, Mahmoud AM, Williams SB, Davis JW.

Indian J Urol. 2019 Jan-Mar;35(1):6-17. doi: 10.4103/iju.IJU_355_18. Review.

18.

Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?

Reichard CA, Nyame YA, Sundi D, Tosoian J, Wilkins L, Alam R, Achim MF, Wang X, Stephenson AJ, Klein EA, Ross AE, Davis JW, Chapin BF.

BJU Int. 2019 Aug;124(2):282-289. doi: 10.1111/bju.14671. Epub 2019 Feb 10.

PMID:
30653804
19.

Los Seres Humanos Matter: A Hispanic Health Story from Texas.

Davis JW.

J Am Board Fam Med. 2019 Jan-Feb;32(1):115-117. doi: 10.3122/jabfm.2019.01.180207.

20.

Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab.

Visvanathan S, Baum P, Vinisko R, Schmid R, Flack M, Lalovic B, Kleiner O, Fuentes-Duculan J, Garcet S, Davis JW, Grebe KM, Fine JS, Padula SJ, Krueger JG.

J Allergy Clin Immunol. 2019 Jun;143(6):2158-2169. doi: 10.1016/j.jaci.2018.11.042. Epub 2018 Dec 20.

21.

AUA Publications: A Digital, Online and Interactive Future.

Davis JW.

J Urol. 2019 Jan;201(1):42-43. doi: 10.1097/01.ju.0000550110.72161.4c. No abstract available.

PMID:
30577386
22.

Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort.

Wang Q, Gregg JR, Gu J, Ye Y, Chang DW, Davis JW, Thompson TC, Kim J, Logothetis CJ, Wu X.

Oncoimmunology. 2018 Oct 29;8(1):e1483303. doi: 10.1080/2162402X.2018.1483303. eCollection 2019.

PMID:
30546938
23.

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance.

Kim HL, Li P, Huang HC, Deheshi S, Marti T, Knudsen B, Abou-Ouf H, Alam R, Lotan TL, Lam LLC, du Plessis M, Davicioni E, Fleshner N, Lane BR, Ross AE, Davis JW, Mohler JL, Trock BJ, Klein EA, Tosoian JJ, Hyndman ME, Bismar TA.

Prostate Cancer Prostatic Dis. 2019 Sep;22(3):399-405. doi: 10.1038/s41391-018-0101-6. Epub 2018 Dec 12.

PMID:
30542054
24.

Determining the impact of culture on venous thromboembolism prevention in trauma patients: A Southwestern Surgical Congress Multicenter trial.

Regner JL, Shaver CN; SWSC Multicenter Trials Group.

Am J Surg. 2019 Jun;217(6):1030-1036. doi: 10.1016/j.amjsurg.2018.11.005. Epub 2018 Nov 20.

PMID:
30503515
25.

Use of an Argentine Ant, Linepithema humile, Semiochemical to Deliver an Acute Toxicant.

Gochnour BM, Suiter DR, Davis JW, Huang Q.

Insects. 2018 Nov 23;9(4). pii: E171. doi: 10.3390/insects9040171.

26.

Recommendations from the American College of Surgeons Committee on Trauma's Firearm Strategy Team (FAST) Workgroup: Chicago Consensus I.

Talley CL, Campbell BT, Jenkins DH, Barnes SL, Sidwell RA, Timmerman G, Gross RI, Coburn M, Bailey JA, Eastman A, Ficke J, Kuncir E, Letton RW, Eastridge BJ, Liepert AE, Wilson A, Robinette D, Davis JW, Shalgian C, Michaels H, Weissler MC, Kuhls DA, Bulger EM, Stewart RM.

J Am Coll Surg. 2019 Feb;228(2):198-206. doi: 10.1016/j.jamcollsurg.2018.11.002. Epub 2018 Nov 14. No abstract available.

PMID:
30447396
27.

Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.

Sundi D, Tosoian JJ, Nyame YA, Alam R, Achim M, Reichard CA, Li J, Wilkins L, Schwen Z, Han M, Davis JW, Klein EA, Schaeffer EM, Stephenson AJ, Ross AE, Chapin BF.

Cancer. 2019 Feb 1;125(3):391-397. doi: 10.1002/cncr.31833. Epub 2018 Nov 13.

PMID:
30423193
28.

Impact of elective caesarean section on neonatal retrieval in Western Australia during a 12-year period.

Macallister KJ, Tho LW, Epee-Bekima M, Resnick S, Davis JW.

J Perinatol. 2019 Jan;39(1):34-38. doi: 10.1038/s41372-018-0263-z. Epub 2018 Oct 19.

PMID:
30341400
29.

Complete white out of a single transplanted lung in the immediate postoperative period.

Davis JW, Perry GJ, Chatterjee A.

Heart Lung. 2019 May - Jun;48(3):258-260. doi: 10.1016/j.hrtlng.2018.08.006. Epub 2018 Sep 12.

PMID:
30219593
30.

Focal therapy for localized prostate cancer: is there a "middle ground" between active surveillance and definitive treatment?

Demirel CH, Altok M, Davis JW.

Asian J Androl. 2018 Aug 31. doi: 10.4103/aja.aja_64_18. [Epub ahead of print]

31.

Ischemic Evaluation in Patients Presenting with Hypertensive Emergency / Urgency and Acute Systolic Heart Failure: Is Coronary Angiography Required for all?

Davis JW, Almubarak M, Mukherjee A, McElwee SK, Leesar MA, Chatterjee A.

Cardiovasc Revasc Med. 2019 Jun;20(6):492-495. doi: 10.1016/j.carrev.2018.08.011. Epub 2018 Aug 16.

PMID:
30177272
32.

Selective IL-23 Inhibition by Risankizumab Modulates the Molecular Profile in the Colon and Ileum of Patients With Active Crohn's Disease: Results From a Randomised Phase II Biopsy Sub-study.

Visvanathan S, Baum P, Salas A, Vinisko R, Schmid R, Grebe KM, Davis JW, Wallace K, Böcher WO, Padula SJ, Fine JS, Panés J.

J Crohns Colitis. 2018 Nov 9;12(10):1170-1179. doi: 10.1093/ecco-jcc/jjy099.

33.

Unintended consequences of decreased PSA-based prostate cancer screening.

Ahlering T, Huynh LM, Kaler KS, Williams S, Osann K, Joseph J, Lee D, Davis JW, Abaza R, Kaouk J, Patel V, Kim IY, Porter J, Hu JC.

World J Urol. 2019 Mar;37(3):489-496. doi: 10.1007/s00345-018-2407-3. Epub 2018 Jul 12. Erratum in: World J Urol. 2019 Jul 22;:.

PMID:
30003374
34.

Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research.

Altok M, Kim B, Patel BB, Shih YT, Ward JF, McRae SE, Chapin BF, Pisters LL, Pettaway CA, Kim J, Demirel HC, Davis JW.

Prostate Cancer Prostatic Dis. 2018 Nov;21(4):524-532. doi: 10.1038/s41391-018-0056-7. Epub 2018 Jul 9.

PMID:
29988098
35.

Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: A unique vascular transcriptomic signature.

Brown SM, Meuth AI, Davis JW, Rector RS, Bender SB.

Pharmacol Res. 2018 Aug;134:100-108. doi: 10.1016/j.phrs.2018.06.002. Epub 2018 Jun 2.

36.

Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.

Vasanthakumar A, Davis JW, Abunimeh M, Söderholm J, Zha J, Dumas EO, Cohen DE, Waring JF, Lagging M.

PLoS One. 2018 May 31;13(5):e0198296. doi: 10.1371/journal.pone.0198296. eCollection 2018.

37.

Salvage topical therapy for upper tract urothelial carcinoma.

Balasubramanian A, Metcalfe MJ, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF.

World J Urol. 2018 Dec;36(12):2027-2034. doi: 10.1007/s00345-018-2349-9. Epub 2018 May 26.

PMID:
29804202
38.

Extended Pelvic Lymph Node Dissection in Bladder Cancer.

Li R, Petros FG, Davis JW.

J Endourol. 2018 May;32(S1):S49-S54. doi: 10.1089/end.2017.0712.

PMID:
29774757
39.

After the embo: predicting non-hemorrhagic indications for splenectomy after angioembolization in patients with blunt trauma.

Bilello JF, Sharp VL, Dirks RC, Kaups KL, Davis JW.

Trauma Surg Acute Care Open. 2018 Feb 5;3(1):e000159. doi: 10.1136/tsaco-2017-000159. eCollection 2018.

40.

Current outcomes of blunt open pelvic fractures: how modern advances in trauma care may decrease mortality.

Siada SS, Davis JW, Kaups KL, Dirks RC, Grannis KA.

Trauma Surg Acute Care Open. 2017 Dec 27;2(1):e000136. doi: 10.1136/tsaco-2017-000136. eCollection 2017.

41.

The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature.

Eissa A, Elsherbiny A, Coelho RF, Rassweiler J, Davis JW, Porpiglia F, Patel VR, Prandini N, Micali S, Sighinolfi MC, Puliatti S, Rocco B, Bianchi G.

Minerva Urol Nefrol. 2018 Oct;70(5):462-478. doi: 10.23736/S0393-2249.18.03081-3. Epub 2018 Apr 17. Review.

42.

Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes.

Reichard CA, Gregg JR, Achim MF, Aparicio AM, Pettaway CA, Pisters LL, Ward JF, Davis JW, Chapin BF.

Eur Urol. 2018 Aug;74(2):140-143. doi: 10.1016/j.eururo.2018.03.031. Epub 2018 Apr 12.

PMID:
29656854
43.

Identification of HLA-DRB1 association to adalimumab immunogenicity.

Liu M, Degner J, Davis JW, Idler KB, Nader A, Mostafa NM, Waring JF.

PLoS One. 2018 Apr 3;13(4):e0195325. doi: 10.1371/journal.pone.0195325. eCollection 2018.

44.

Interspecies variation in the susceptibility of adult Pacific salmon to toxic urban stormwater runoff.

McIntyre JK, Lundin JI, Cameron JR, Chow MI, Davis JW, Incardona JP, Scholz NL.

Environ Pollut. 2018 Jul;238:196-203. doi: 10.1016/j.envpol.2018.03.012. Epub 2018 Mar 20.

45.

Multiparametric magnetic resonance imaging: Overview of the technique, clinical applications in prostate biopsy and future directions.

Demirel HC, Davis JW.

Turk J Urol. 2018 Mar;44(2):93-102. doi: 10.5152/tud.2018.56056. Epub 2018 Mar 1. Review.

46.

Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.

Altok M, Babaian K, Achim MF, Achim GC, Troncoso P, Matin SF, Chapin BF, Davis JW.

BJU Int. 2018 Jul;122(1):66-75. doi: 10.1111/bju.14164. Epub 2018 Mar 25.

47.

A method for the long-term cultivation of mammalian cells in the absence of oxygen: Characterization of cell replication, hypoxia-inducible factor expression and reactive oxygen species production.

Plotkin BJ, Davis JW, Strizzi L, Lee P, Christoffersen-Cebi J, Kacmar J, Rivero OJ, Elsayed N, Zanghi N, Ito B, Sigar IM.

Tissue Cell. 2018 Feb;50:59-68. doi: 10.1016/j.tice.2017.12.004. Epub 2017 Dec 15.

PMID:
29429519
48.

Base deficit is superior to lactate in trauma.

Davis JW, Dirks RC, Kaups KL, Tran P.

Am J Surg. 2018 Apr;215(4):682-685. doi: 10.1016/j.amjsurg.2018.01.025. Epub 2018 Jan 31.

PMID:
29409590
49.

Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy.

Spratt DE, Dai DLY, Den RB, Troncoso P, Yousefi K, Ross AE, Schaeffer EM, Haddad Z, Davicioni E, Mehra R, Morgan TM, Rayford W, Abdollah F, Trabulsi E, Achim M, Tapia ELN, Guerrero M, Karnes RJ, Dicker AP, Hurwitz MA, Nguyen PL, Feng FFY, Freedland SJ, Davis JW.

Eur Urol. 2018 Jul;74(1):107-114. doi: 10.1016/j.eururo.2017.11.024. Epub 2017 Dec 10.

50.

Positive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancer.

Chapin BF, Nguyen JN, Achim MF, Navai N, Williams SB, Prokhorova IN, Wang X, Tapia EMLN, Davis JW, Troncoso P.

Prostate Cancer Prostatic Dis. 2018 Jun;21(2):221-227. doi: 10.1038/s41391-017-0019-4. Epub 2017 Dec 11.

PMID:
29230008

Supplemental Content

Loading ...
Support Center